Loading…
Loading…

| NRIXNRIXNurix Therapeutics, Inc. | Nurix Therapeutics, Inc. | $26.49 | $2.9B |
| XNCRXNCRXencor, Inc. | Xencor, Inc. | $29.35 | $2.2B |
| PCRXPCRXPacira BioSciences, Inc. | Pacira BioSciences, Inc. | $36.39 | $1.5B |
| RAPPRAPPRapport Therapeutics, Inc. Common Stock | Rapport Therapeutics, Inc. Common Stock | $25.10 | $1.2B |
| AMPHAMPHAmphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals, Inc. | $26.98 | $1.1B |
| IRMDIRMDIRadimed Corporation | IRadimed Corporation | $78.65 | $1.0B |
| COLLCOLLCollegium Pharmaceutical, Inc. | Collegium Pharmaceutical, Inc. | $24.18 | $787.1M |
| PHATPHATPhathom Pharmaceuticals, Inc. | Phathom Pharmaceuticals, Inc. | $5.96 | $482.2M |
| EMBCEMBCEmbecta Corp. | Embecta Corp. | $6.50 | $368.3M |
| BBOTBBOTBridgeBio Oncology Therapeutics Inc. | BridgeBio Oncology Therapeutics Inc. | $2.67 | $214.4M |